Current technique and results for extended pelvic lymph node dissection during robot-assisted radical prostatectomy

Roger Li, Firas G. Petros, Janet B. Kukreja, Stephen B. Williams, John W. Davis

Research output: Contribution to journalReview article

2 Scopus citations


The practice of extended pelvic lymph node dissection (ePLND) remains one of the most controversial topics in the management of clinically localized prostate cancer. Although most urologists agree on its benefit for staging and prognostication, the role of the ePLND in cancer control continues to be debated. The increased perioperative morbidity makes it unpalatable, especially in patients with low likelihood of lymph node disease. With the advent of robotic assisted laparoscopic prostatectomy, many surgeons were slow to adopt ePLND in the robotic setting. In this study, we summarize the evidence for the prognostic and therapeutic roles of ePLND, review the clinical tools used for lymph node metastasis prediction and survey the numerous experiences of ePLND compiled by robotic urologic surgeons over the years.

Original languageEnglish (US)
Pages (from-to)S155-S164
JournalInvestigative and Clinical Urology
StatePublished - Jan 1 2016



  • Lymph node excision
  • Prostate neoplasms
  • Prostatectomy
  • Robotic surgical procedures

ASJC Scopus subject areas

  • Urology

Cite this